Cognitive function and quality of life in mild thyroid hormone deficiency

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

Volumn 8, Issue 2, 2014, Pages 124-134

  Tognini, Sara ^a   Pasqualetti, Giuseppe ^a   Calsolaro, Valeria ^a   Polini, Antonio ^a   Monzani, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cognition; Elderly; Hypothyroidism; Quality of life; Subclinical hypothyroidism; Thyroiditis

Indexed keywords

LEVOTHYROXINE; THYROID HORMONE;

ARTICLE; AUTOIMMUNE DISEASE; AWARENESS; COGNITION; HEALTH STATUS; HORMONE DEFICIENCY; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SUBCLINICAL HYPOTHYROIDISM; SYSTEMATIC REVIEW; THYROID DISEASE; THYROID HORMONE DEFICIENCY; BRAIN; COGNITIVE DEFECT; COMPLICATION; DEFICIENCY; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRODROMAL SYMPTOM; PSYCHOLOGY;

BRAIN; COGNITION DISORDERS; HUMANS; HYPOTHYROIDISM; NEURONAL PLASTICITY; PRODROMAL SYMPTOMS; QUALITY OF LIFE; THYROID HORMONES;

EID: 84905653566     PISSN: 18722148     EISSN: 22123334     Source Type: Journal    
DOI: 10.2174/1872214808666140723111533     Document Type: Article

References (146)

1. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012; 379(9821): 1142-1154.
2. Ceresini G, Morganti S, Maggio M, Usberti E, Fiorino I, Artoni A, et al. Subclinical thyroid disease in elderly subjects. Acta Biomed 2010; 81(1): 31-36.
3. th Eds. The Thyroid, A Fundamental and Clinical Text. Philadelphia: Lippincott Williams and Wilkins 2005; 1072-1078.
4. Evered D, Young ET, Ormston BJ, Menzies R, Smith PA, Hall R. Treatment of hypothyroidism: A reappraisal of thyroxine therapy. Br Med J 1973; 3(5872): 131-134.
5. Woeber KA. Subclinical thyroid dysfunction. Arch Intern Med 1997; 157(10):1065-1068.
6. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 2004; 291(2): 228-238.
7. Papi G, Uberti ED, Betterle C, Carani C, Pearce EN, Braverman LE, et al. Subclinical hypothyroidism. Curr Opin Endocrinol Diabetes Obes 2007; 14(3): 197-208.
8. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med 2001; 345(4): 260-265.
9. Franklyn JA. The thyroid-too much and too little across the ages. The consequences of subclinical thyroid dysfunction. Clin Endo-crinol (Oxf) 2013; 78(1): 1-8.
10. Klaver EI, van Loon HC, Stienstra R, Links TP, Keers JC, Kema IP, et al. Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study. Thyroid 2013; 23(9): 1066-1073.
11. Razvi S, Ingoe LE, McMillan CV, Weaver JU. Health status in patients with sub-clinical hypothyroidism. Eur J Endocrinol 2005; 152(5): 713-717.
12. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349(9068):1793-1796.
13. Chavanne D, Constans T, Petit A, Mondon K, Hommet C. Hypo-thyroidism and cognition in the elderly. Geriatr Psychol Neuropsy-chiatr Vieil 2011; 9(4): 477-489.
14. Prinz PN, Scanlan JM, Vitaliano PP, Moe KE, Borson S, Toivola B, et al. Thyroid hormones: Positive relationships with cognition in healthy, euthyroid older men. J Gerontol A Biol Sci Med Sci 1999; 54(3): 111-116.
15. Volpato S, Guralnik JM, Fried LP, Remaley AT, Cappola AR, Launer LJ. Serum thyroxine level and cognitive decline in euthy-roid older women. Neurology 2002; 58(7):1055-1061.
16. Breznitz, S. Method and apparatus for testing and training cognitive ability. US6632174 (2003).
17. Rivas M, Naranjo JR. Thyroid hormones, learning and memory. Genes Brain Behav 2007; 6 (Suppl 1): 40-44.
18. Schroeder AC, Privalsky ML. Thyroid hormones, T3 and T4, in the brain. Front Endocrinol (Lausanne) 2014; 31; 5: 40.
19. Patel J, Landers K, Li H, Mortimer RH, Richard K. Thyroid hormones and fetal neurological development. J Endocrinol 2011; 209(1): 1-8.
20. Bernal J. Thyroid hormones and brain development. Vitam Horm 2005; 71: 95-122.
21. Zoeller RT. New insights into thyroid hormone action in the developing brain: The importance of T3 degradation. Endocrinology 2010; 151(11): 5089-5091.
22. Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: Clinical observations and experimental findings. J Neuroendocrinol 2004; 16(10): 809-818.
23. Calvo R, Obregón MJ, Ruiz de Oña C, Escobar del Rey F, Mor-reale de Escobar G. Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3, 5, 3'-triiodothyronine in the protection of the fetal brain. J Clin Invest 1990; 86(3): 889-899.
24. Heuer H. The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab 2007; 21: 265-276.
25. Chatonnet F, Picou F, Fauquier T, Flamant F. Thyroid hormone action in cerebellum and cerebral cortex development. J Thyroid Res 2011; 2011: 145762.
26. Wallis K, Dudazy S, Van Hogerlinden M, Nordstrom K, Mittag J, Vennstrom B. The thyroid hormone receptor alpha 1 protein is expressed in embryonic post mitotic neurons and persists in most adult neurons. Mol Endocrinol 2010; 24: 1904-1916.
27. Crantz FR, Silva JE, Larsen PR. An analysis of the sources and quantity of 3, 5, 30-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 1982; 110: 367-375.
28. Galton VA, Schneider MJ, Clark AS, St Germain DL. Life without thyroxine to 3, 5, 3'-triiodothyronine conversion: Studies in mice devoid of the 5'-deiodinases. Endocrinology 2009; 150: 2957-2963.
29. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, StGermain DL, Galton VA. Targeted disruption of the type-2-selenodeiodinasegene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 2001; 15: 2137-2148.
30. Mirescu C, Gould E. Stress and adult neurogenesis. Hippocampus 2006; 16: 233-238.
31. Fu AL, Zhou CY, Chen X. Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer's disease. Neuropharmacol-ogy 2010; 58: 722-729.
32. Ming G-L, Song H. Adult neurogenesis in the mammalian brain: Significant answers and significant questions. Neuron 2011; 70: 687-702.
33. Sanai N, Nguyen T, Ihrie RA, Mirzadeh Z, Tsai H-H, Wong M, et al. Corridors of migrating neurons in the human brain and their decline during infancy. Nature 2011; 478: 382-386.
34. López-Juárez A, Remaud S, Hassani Z, Jolivet P, Pierre Simons J, Sontag T, et al. Thyroid hormone signaling acts as a neurogenic switch by repressing SOX2 in the adult neural stemcell niche. Cell Stem Cell 2012; 10: 531-543.
35. Kapoor R, Desouza LA, Nanavaty IN, Kernie SG, Vaidya VA. Thyroid hormone accelerates the differentiation of adult hippocam-pal progenitors. J Neuroendocrinol 2012; 24: 1259-1271.
36. Gage, F.H., Ray, J. Method for production of neuroblasts. US6265175 (2001).
37. Lemkine GF, Raj A, Alfama G, Turque N, Hassani Z, Alegria-Prévot O, et al. Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor. FASEBJ 2005; 19: 863-865.
38. Montero-Pedrazuela A, Venero C, Lavado-Autric R, Fernández-Lamo I, García-Verdugo JM, Bernal J, et al. Modulation of adult hippocampal neurogenesis by thyroid hormones: Implications in depressive-like behavior. Mol Psychiatry 2006; 11: 361-371.
39. Ambrogini P, Cuppini R, Ferri P, Mancini C, Ciaroni S, Voci A, et al. Thyroid hormones affect neurogenesis in the dentate gyrus of adult rat. Neuroendocrinology 2005; 81: 244-253.
40. Desouza LA, Ladiwala U, Daniel SM, Agashe S, Vaidya RA, Vai-dya VA. Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain. Mol Cell Neurosci 2005; 29: 414-426.
41. Favaro R, Valotta M, Ferri AL, Latorre E, Mariani J, Giachino C, et al. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci 2009; 12(10): 1248-1256.
42. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
43. Chen, J., Garza, D., Li, H., Stevenson, S.C., Wu, Z. Genes involved in mitochondrial biogenesis. WO2008098995 (2008).
44. Long YC, Tan TMC, Inoue T, Tang BL. The biochemistry and cell biology of aging: Metabolic regulation through mitochondrial signaling. Am J Physiol Endocrinol Metab 2014; 306: E581-E591.
45. Campos Costa I, Nogueira Carvalho H, Fernandes L. Aging, cir-cadian rhythms and depressive disorders: A review. Am J Neu-rodegener Dis 2013; 2: 228-246.
46. Kimiwada T, Sakurai M, Ohashi H, Aoki S, Tominaga T, Wada K. Clock genes regulate neurogenic transcription factors, including NeuroD1, and the neuronal differentiation of adult neural stem/progenitor cells. Neurochem Int 2009; 54: 277-285.
47. Wulf A, Harneit A, Kröger M, Kebenko M, Wetzel MG, Weitzel JM. T3-mediated expression of PGC-1alpha via a far up stream located thyroid hormone response element. Mol Cell Endocrinol 2008; 287: 90-95.
48. Diez D, Grijota-Martinez C, Agretti P, DeMarco G, Tonacchera M, Pinchera A, et al. Thyroid hormone action in the adult brain: Gene expression profiling of the effects of single and multiple doses of triiodo-L-thyronine in the rat striatum. Endocrinology 2008; 149(8): 3989-4000.
49. Herholz K. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Rev Neurother 2010; 10(11): 1667-1673.
50. Channing, Y.S., WU, S.-G., Wang, T., Wangxing, Y. Method for building congenital hypothyroidism rat models. CN102715126 (2012).
51. Harlan, D.M., June, C.H. Transgenic animal model for autoimmune diseases. WO1994023760 (1994).
52. Ge JF, Peng L, Hu CM, Wu TN. Impaired learning and memory performance in a subclinical hypothyroidism rat model induced by hemi-thyroid electro-cauterisation. J Neuroendocrinol 2012; 24(6): 953-961.
53. Klieverik LP, Sauerwein HP, Ackermans MT, Boelen A, Kalsbeek A, Fliers E. Effects of thyrotoxicosis and selective hepatic auto-nomic denervation on hepatic glucose metabolism in rats. Am J Physiol Endocrinol Metab 2008; 294(3): 513-520.
54. Fliers E, Klieverik LP, Kalsbeek A. Novel neural pathways for metabolic effects of thyroid hormone. Trends Endocrinol Metab 2010; 21(4): 230-236.
55. Clark, J.F., Degrauw, T., Kaddurah-Daouk, R. Methods of treating cognitive dysfunction by modulating brain energy metabolism. EP1567180 (2005).
56. Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar D, Seghers A, et al. Cerebral blood flow and glucose metabolism in hypothy-roidism: A positron emission tomography study. J Clin Endocrinol Metab 2001; 86(8): 3864-3870.
57. Bauer M, Silverman DH, Schlagenhauf F, London ED, Geist CL, van Herle K, et al. Brain glucose metabolism in hypothyroidism: A positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab 2009; 94(8): 2922-2929.
58. Scheinberg P. Cerebral circulation and metabolism in hyperthyroid-ism. J Clin Invest 1950; 29(8): 1010-1013.
59. Smith CD, Ain KB. Brain metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy. Lancet 1995; 345(8950): 619-620.
60. Miao Q, Zhang S, Guan YH, Ye HY, Zhang ZY, Zhang QY, et al. Reversible changes in brain glucose metabolism following thyroid function normalization in hyperthyroidism. AJNR Am J Neurora-diol 2011; 32(6): 1034-1042.
61. Jahagirdar V, McNay EC. Thyroid hormone's role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processes. Metab Brain Dis 2012; 27(2): 101-111.
62. Iglesias T, Caubín J, Zaballos A, Bernal J, Muñoz A. Identification of the mitochondrial NADH dehydrogenase subunit 3 (ND3) as a thyroid hormone regulated gene by whole genome PCR analysis. Biochem Biophys Res Commun 1995; 210(3): 995-1000.
63. Das K, Chainy GB. Thyroid hormone influences antioxidant defense system in adult rat brain. Neurochem Res 2004; 29(9): 1755-1766.
64. Venditti P, Di Meo S. Thyroid hormone-induced oxidative stress. Cell Mol Life Sci 2006; 63(4): 414-434.
65. Cano-Europa E, Pérez-Severiano F, Vergara P, Ortiz-Butrón R, Ríos C, Segovia J, et al. Hypothyroidism induces selective oxidative stress in amygdala and hippocampus of rat. Metab Brain Dis 2008; 23(3): 275-287.
66. Morrison CD, Pistell PJ, Ingram DK, Johnson WD, Liu Y, Fernandez-Kim SO, et al. High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: Implications for decreased Nrf2 signaling. J Neurochem 2010; 114(6): 1581-1589.
67. Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 2002; 23(6): 288-293.
68. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease is this type 3 diabetes? J Alzheimers Dis 2005; 7(1): 63-80.
69. Craft S. Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment. Curr Alzheimer Res 2007; 4(2): 147-152.
70. Belakavadi M, Dell J, Grover GJ, Fondell JD. Thyroid hormone suppression of p-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. Mol Cell Endocrinol 2011; 339(1-2): 72-80.
71. Davis JD, Podolanczuk A, Donahue JE, Stopa E, Hennessey JV, Luo LG, et al. Thyroid hormone levels in the prefrontal cortex of post-mortem brains of Alzheimer's disease patients. Curr Aging Sci 2008; 1(3): 175-181.
72. Guidelines for the evaluation of dementia and age-related cognitive decline: American Psychological Association Presidential Task Force on the assessment of age-consistent memory decline & dementia Washington DC US. American Psychologist 1998; 53(12): 1298-1303.
73. Johonson, E.J. Early detection of cognition impairment in elderly population. US20110105855 (2011).
74. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004; 292(21): 2591-2599.
75. Tan ZS, Beiser A, Vasan RS, Au R, Auerbach S, Kiel DP, et al. Thyroid function and the risk of Alzheimer disease: The Framingham Study. Arch Intern Med 2008; 168(14):1514-1520.
76. Ceresini G, Lauretani F, Maggio M, Ceda GP, Morganti S, Usberti E, et al. Thyroid function abnormalities and cognitive impairment in elderly people: Results of the Invecchiare in Chianti study. J Am Geriatr Soc 2009; 57(1): 89-93.
77. Roberts LM, Pattison H, Roalfe A, Franklyn J, Wilson S, Hobbs FD, et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Int Med 2006; 145: 573-581.
78. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab 2006; 91: 145-153.
79. Monzani F, Del Guerra P, Caraccio N, Pruneti CA, Pucci E, Luisi M, et al. Subclinical hypothyroidism: Neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 1993; 71(5): 367-371.
80. Osterweil D, Syndulko K, Cohen SN, Pettler-Jennings PD, Hershman JM, Cummings JL, et al. Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc 1992; 40(4): 325-335.
81. St John JA, Henderson VW, Gatto NM, McCleary CA, Spencer CA, Hodis HN, et al. Mildly elevated TSH and cognition in middle-aged and older adults. Thyroid 2009; 19(2): 111-117.
82. Correia N, Mullally S, Cooke G, Tun TK, Phelan N, Feeney J, et al. Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism. J Clin Endocrinol Metab 2009; 94(10): 3789-3797.
83. Baldini IM, Vita A, Mauri MC, Amodei V, Carrisi M, Bravin S, et al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21(6): 925-935.
84. Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS. Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects. Thyroid 2007; 17(3): 249-258.
85. Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque MS, et al. A randomized controlled trial of the effect of thyroxine re-placement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: The Birmingham Elderly Thyroid Study. J Clin Endocrinol Metab 2010; 95: 3623-3632.
86. Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC cognitive function and ageing study. Psychoneuroendocrinology 2008; 33(7): 1013-1022.
87. Ross, R. Traetment of hypothyroidism. WO2007125295 (2007).
88. del Ser Quijano T, Delgado C, Martínez Espinosa S, Vázquez C. Cognitive deficiency in mild hypothyroidism. Neurologia 2000; 15(5): 193-198.
89. Park YJ, Lee EJ, Lee YJ, Choi SH, Park JH, Lee SB, et al. Sub-clinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QOL) in elderly subjects. Arch Gerontol Geriatr 2010; 50(3): e68-e73.
90. Pasqualetti G, Tognini S, Polini A, Caraccio N, Monzani F. Sub-clinical hypothyroidism and heart failure risk in older people. En-docr Metab Immune Disord Drug Targets 2013; 13(1): 13-21.
91. Pasqualetti G, Tognini S, Polini A, Caraccio N, Monzani F. Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab 2013; 98(6): 2256-2266.
92. Yamamoto N, Ishizawa K, Ishikawa M, Yamanaka G, Yamanaka T, Murakami S, et al. Cognitive function with subclinical hypothy-roidism in elderly people without dementia: One year follow up. Geriatr Gerontol Int 2012; 12(1): 164-165.
93. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2006; 91(12): 5076-5082.
94. Formiga F, Ferrer A, Padros G, Contra A, Corbella X, Pujol R; Octabaix Study Group. Thyroid status and functional and cognitive status at baseline and survival after 3 years of follow-up: The OC-TABAIX study. Eur J Endocrinol 2013; 170(1): 69-75.
95. Wijsman LW, de Craen AJ, Trompet S, Gussekloo J, Stott DJ, Rodondi N, et al. Subclinical thyroid dysfunction and cognitive decline in old age. PLoS One 2013; 8(3): e59199.
96. Jarrige-Leprado, A., Beurdelev, P., Pallares, D., Rouet, F., Bracco, L., Process and method for diagnosing Alzheimer's disease US8481701 (2013).
97. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Bre-teler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf) 2000; 53(6): 733-737.
98. Parsaik AK, Singh B, Roberts RO, Pankratz S, Edwards KK, Geda YE, et al. Hypothyroidism and risk of mild cognitive impairment in elderly persons: A population-based study. JAMA Neurol 2014; 71(2): 201-207.
99. Joffe RT, Pearce EN, Hennessey JV, Ryan JJ, Stern RA. Subclini-cal hypothyroidism, mood, and cognition in older adults: A review. Int J Geriatr Psychiatry 2013; 28(2): 111-118.
100. WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL) position paper from the WHO. Soc Sci Med 1995; 41: 1043-1049.
101. Razvi S, McMillan CV, Weaver JU. Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: A systematic qualitative review. Clin Endocrinol (Oxf) 2005; 63(6): 617-624.
102. Mousa, S.A., Davis, F.B., Davis, P.J. Thyroid hormone analogs and methods of use US20100152543 (2014).
103. Bianchi GP, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M, et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res 2004; 13: 45-54.
104. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, et al. Combined thyroxine/liothyronine treatment does not improve wellbeing, quality of life, or cognitive function compared to thy-roxine alone: A randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 2003; 88: 4543-4550.
105. Larisch R, Kley K, Nikolaus S, Sitte W, Franz M, Hautzel H, et al. Depression and anxiety in different thyroid function states. Horm Metab Res 2004; 36(9): 650-653.
106. Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf) 2007; 66(4): 548-556.
107. McMillan CV, Bradley C, Woodcock A, Razvi S, Weaver JU. Design of new questionnaires to measure quality of life and treat-ment satisfaction in hypothyroidism. Thyroid 2004; 14(11): 916-925.
108. McMillan C, Bradley C, Razvi S, Weaver J. Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: The ThyDQOL and ThySRQ. Value Health 2008; 11(2): 285-94.
109. Quinque EM, Villringer A, Kratzsch J, Karger S. Patient-reported outcomes in adequately treated hypothyroidism - insights from the German versions of ThyDQOL, ThySRQ and ThyTSQ. Health Qual Life Outcomes 2013; 11: 68.
110. Watt T, Hegedüs L, Rasmussen AK, Groenvold M, Bonnema SJ, Bjorner JB, et al. Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives. Thyroid 2007; 17(7): 647-654.
111. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29(1): 76-131.
112. Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for depression in the elderly. Arch Gerontol Geri-atr 2007; 44(1): 21-28.
113. Wu EL, Chien IC, Lin CH, Chou YJ, Chou P. Increased risk of hypothyroidism and hyperthyroidism in patients with major depressive disorder: A population-based study. J Psychosom Res 2013; 74(3): 233-237.
114. Jaeschke R, Guyatt G, Cook D, Harper S, Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Qual Life Res 1994; 3(5): 323-327.
115. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: Results of an international, randomized, controlled study. J Clin Endocrinol Metab 2006; 91(3): 926-932.
116. Taïeb D, Sebag F, Cherenko M, Baumstarck-Barrau K, Fortanier C, Farman-Ara B, et al. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): A randomized controlled study. Clin Endocrinol (Oxf) 2009; 71(1): 115-123.
117. Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W, et al. Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 2006; 15(4): 695-703.
118. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-534.
119. Mainenti MR, Vigário PS, Teixeira PF, Maia MD, Oliveira FP, Vaisman M. Effect of levothyroxine replacement on exercise performance in subclinical hypothyroidism. J Endocrinol Invest 2009; 32(5): 470-473.
120. Reuters VS, Teixeira Pde F, Vigário PS, Almeida CP, Buescu A, Ferreira MM, et al. Functional capacity and muscular abnormalities in subclinical hypothyroidism. Am J Med Sci 2009; 338(4): 259-263.
121. Caraccio N, Dardano A, Monzani F. Subclinical thyroid disease and cardiovascular disease. JAMA 2005; 293(9): 1059-1060.
122. Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, et al. The link between thyroid autoimmunity (antithyroid per-oxidase autoantibodies) with anxiety and mood disorders in the community: A field of interest for public health in the future. BMC Psychiatry 2004; 18: 4: 25.
123. Leclère J, Cousty C, Schlienger JL, Wémeau JL. Subclinical hypo-thyroidism and quality of life of women aged 50 or more with hy-percholesterolemia: Results of the HYOGA study. Presse Med 2008; 37(11): 1538-1546.
124. Vigário P, Teixeira P, Reuters V, Almeida C, Maia M, Silva M, et al. Perceived health status of women with overt and subclinical hypothyroidism. Med Princ Pract 2009; 18(4): 317-322.
125. Vigário Pdos S, Vaisman F, Coeli CM, Ward L, Graf H, Carvalho G, et al. Inadequate levothyroxine replacement for primary hypo-thyroidism is associated with poor health-related quality of life-a Brazilian multicentre study. Endocrine 2013; 44(2): 434-440.
126. Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokat-lioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 2006; 37(1): 133-139.
127. Ladenson PW. Psychological wellbeing in patients. Clin Endocri-nol (Oxf) 2002; 57(5): 575-576.
128. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatol-ogy 1999; 30(5): 1299-1301.
129. Wenger NK. Quality of life issues in hypertension: Consequences of diagnosis and considerations in management. Am Heart J 1988; 116: 628-632.
130. Baldini M, Colasanti A, Orsatti A, Airaghi L, Mauri MC, Cappelli-ni MD. Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: The effects of L-thyroxine. Prog Neu-ropsychopharmacol Biol Psychiatry 2009; 33(5): 854-859.
131. Bould H, Panicker V, Kessler D, Durant C, Lewis G, Dayan C, et al. Investigation of thyroid dysfunction is more likely in patients with high psychological morbidity. Fam Pract 2012; 29(2):163-167
132. Virgini VS, Wijsman LW, Rodondi N, Bauer DC, Kearney PM, Gussekloo J, et al. On behalf of the Prosper Study Group SP. Sub-clinical thyroid dysfunction and functional capacity among elderly. Thyroid 2014; 24(2): 208-214.
133. Simonsick EM, Newman AB, Ferrucci L, Satterfield S, Harris TB, Rodondi N, et al. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med 2009; 169(21): 2011-2017.
134. Surks MI, Hollowell JG. Age-specific distribution of serum thy-rotropin and antithyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J Clin En-docrinol Metab 2007; 92(12): 4575-4582.
135. Díez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: An analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endo-crinol Metab 2004; 89(10): 4890-4897.
136. Grabe HJ, Völzke H, Lüdemann J, Wolff B, Schwahn C, John U, et al. Mental and physical complaints in thyroid disorders in the general population. Acta Psychiatr Scand 2005; 112(4): 286-293.
137. Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC, et al. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: A prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 2011; 21(2): 161-167.
138. Bazzichi L, Rossi A, Zirafa C, Monzani F, Tognini S, Dardano A, et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol Int 2012; 32(2): 335-341.
139. Dardano A, Bazzichi L, Bombardieri S, Monzani F. Symptoms in euthyroid Hashimoto's thyroiditis: Is there a role for autoimmunity itself? Thyroid 2012; 22(3): 334-335.
140. Dickson A, Toft A, O'Carroll RE. Neuropsychological functioning, illness perception, mood and quality of life in chronic fatigue syndrome, autoimmune thyroid disease and healthy participants. Psy-chol Med 2009; 39(9): 1567-1576.
141. Ginger, L.G., Anthony, P.Z. Process for producing thyroxine. US2889363 (1959).
142. Boerth, N.J., Moncrief, J.S., Olon, L.P. Piccariello, T. Controlled absorption of mixed thyroyd hormone formulations. EP1565171 (2005).
143. Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M, et al. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. Am J Med 2002; 112(5): 348-354.
144. Reuters VS, Almeida Cde P, Teixeira Pde F, Vigário Pdos S, Fer-reira MM, Castro CL, et al. Effects of subclinical hypothyroidism treatment on psychiatric symptoms, muscular complaints, and quality of life. Arq Bras Endocrinol Metabol 2012; 56(2): 128-136.
145. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, en-dothelial function, and quality of life in subclinical hypothyroid-ism: Randomized, crossover trial. J Clin Endocrinol Metab 2007; 92(5): 1715-1723.
146. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, et al. 2013 ETA Guideline: Management of subclinical hypothy-roidism. Eur Thyroid J 2013; 2(4): 215-228.